Therefore, advisably inhibiting PTP1B activity is considered to evoke multiple series of physiological responses to resist T2DM and obesity via facilitating tyrosine phosphorylation of insulin signaling molecules. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.